Research record

Selected publications.

Selected research papers and conference abstracts by Bowhead leaders and collaborators in vaccine development, immunology, glycobiology and clinical AI.

Selected work

Research papers and conference abstracts

Selected works by Bowhead leaders and research collaborators; not all describe Bowhead programs.

Clinical trial matching · 2025

Evaluation of Bowhead Health patient navigator for breast cancer treatment in India: a pilot study

Diaz-Mitoma F. Journal of Clinical Oncology. 2025;43(16_suppl):e13659. ASCO Annual Meeting abstract.

The abstract reports an evaluation using 40 synthetic cases. It is not a prospective clinical study or evidence of patient outcomes.

Read abstract · DOI 10.1200/JCO.2025.43.16_suppl.e13659

Vaccines & clinical trials · 2021

Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine: a phase 3 randomized clinical trial

Vesikari T, Finn A, van Damme P, et al. (including Francisco Diaz-Mitoma). PROTECT study. JAMA Network Open. 2021;4(10):e2128652.

Phase 3 comparison of immunogenicity and safety in a randomized trial.

Read publication · DOI 10.1001/jamanetworkopen.2021.28652

Vaccines · 2019

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Mullane KM, Morrison VA, Camacho LH, et al. (including Francisco Diaz-Mitoma). The Lancet Infectious Diseases. 2019;19(9):1001–1012.

A phase 3 study of an inactivated varicella zoster vaccine in immunocompromised patients with malignancies.

Read publication · DOI 10.1016/S1473-3099(19)30310-X

Vaccines · 2012

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory oligodeoxyribonucleotide and three doses of a licensed vaccine

Halperin SA, Ward B, Cooper C, Predy G, Diaz-Mitoma F, et al. Vaccine. 2012;30(15):2556–2563.

A clinical comparison of investigational and licensed hepatitis B vaccine regimens in healthy adults.

Read publication · DOI 10.1016/j.vaccine.2012.01.087

Vaccines · 2010

Enhancing oral vaccine potency by targeting intestinal M cells

Azizi A, Kumar A, Diaz-Mitoma F, Mestecky J. PLoS Pathogens. 2010;6(11):e1001147.

Research on targeting intestinal M cells as an approach to oral vaccine delivery.

Read publication · DOI 10.1371/journal.ppat.1001147

Vaccine development · 2011

Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses

Sirskyj D, Diaz-Mitoma F, Golshani A, Kumar A, Azizi A. Immunology and Cell Biology. 2011;89(1):81–89.

Describes computational methods for selecting vaccine targets in rapidly changing viruses.

Read publication · DOI 10.1038/icb.2010.65

Antivirals · 1998

Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir

Angel JB, Kumar A, Parato K, Filion LG, Diaz-Mitoma F, et al. Journal of Infectious Diseases. 1998;177(4):898–904.

Reports immune-function findings during combination antiretroviral therapy.

Read publication · DOI 10.1086/515244

Immunology · 1996

IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-α

Daftarian PM, Kumar A, Kryworuchko M, Diaz-Mitoma F. Journal of Immunology. 1996;157(1):12–20.

Examines cytokine signals that affect IL-10 production in human immune cells.

Read publication · DOI 10.4049/jimmunol.157.1.12

Glycoscience · 2023

Cataloging natural sialic acids and other nonulosonic acids (NulOs), and their representation using the Symbol Nomenclature for Glycans

Lewis AL, … Schoenhofen I, Varki A, et al. Glycobiology. 2023.

Catalogues this family of sugars and describes how to represent them with a shared glycan notation.

Read publication · DOI 10.1093/glycob/cwac072

Antivirals · 1996

Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: a randomized, double-blind multicenter trial

Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD. JAMA. 1996;276(1):44–49.

Randomized trial of patient-initiated treatment for early recurrent genital herpes.

Read publication · DOI 10.1001/jama.1996.03540010046029

More publications by Ian C. Schoenhofen: Google Scholar.

A conversation starts the next chapter

Move promising
science forward.

Talk to our team